Int J Med Sci 2020; 17(9):1207-1214. doi:10.7150/ijms.44612

Research Paper

S1P promotes IL-6 expression in osteoblasts through the PI3K, MEK/ERK and NF-κB signaling pathways

Sung-Lin Hu1,2#, Chien-Chung Huang1,3#, Tzu-Ting Tzeng4, Shan-Chi Liu5, Chun-Hao Tsai6,7, Yi-Chin Fong6,8✉, Chih-Hsin Tang1,4,9,10✉

1. School of Medicine, China Medical University, Taichung, Taiwan
2. Department of Family Medicine, China Medical University Hsinchu Hospital, Hsinchu, Taiwan
3. Division of Immunology and Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
4. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
5. Department of Medical Education and Research, China Medical University Beigang Hospital, Yunlin, Taiwan
6. Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan
7. Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan
8. Department of Orthopedic Surgery, China Medical University Beigang Hospital, Yunlin, Taiwan
9. Chinese Medicine Research Center, China Medical University, Taichung, Taiwan
10. Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan
# These authors contributed equally.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Hu SL, Huang CC, Tzeng TT, Liu SC, Tsai CH, Fong YC, Tang CH. S1P promotes IL-6 expression in osteoblasts through the PI3K, MEK/ERK and NF-κB signaling pathways. Int J Med Sci 2020; 17(9):1207-1214. doi:10.7150/ijms.44612. Available from http://www.medsci.org/v17p1207.htm

File import instruction

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease, in which the immune system attacks joint tissue. Interleukin (IL)-6 is a key proinflammatory cytokine in RA progression. Sphingosine-1-phosphate (S1P), a platelet-derived lysophospholipid mediator, reportedly regulates osteoimmunology. Here, we examined the effects of S1P on IL-6 expression in osteoblasts. Our results and records from the Gene Expression Omnibus (GEO) database demonstrate higher levels of IL-6 in patients with RA compared with those with osteoarthritis. Stimulation of osteoblasts with S1P increased mRNA and protein expression of IL-6. PI3K, MEK, ERK and NF-κB inhibitors and their small interfering RNAs (siRNAs) reduced S1P-promoted IL-6 expression. S1P also facilitated PI3K, MEK/ERK and NF-κB signaling cascades. Our results indicate that S1P promotes the expression of IL-6 in osteoblasts via the PI3K, MEK/ERK and NF-κB signaling pathways.

Keywords: S1P, IL-6, Osteoblasts, Arthritis